Coronavirus: BioNTech chief says vaccine approval possible in mid-December

BioNTech’s chief executive Ugur Sahin said Wednesday that the firm’s COVID-19 vaccine could be approved for emergency-use authorization by European and U.S. regulators as early as mid-December, under ideal conditions. He added that distribution could begin in the second half of December to Europe and the U.S.